Ampligen

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.) Forty Seven Inc (NASDAQ: FTSV) Masimo Corporation (NASDAQ: MASI) Seattle Genetics, Inc. (NASDAQ: SGEN) Vertex Pharmaceuticals Incorporated (...

The news was mediocre at best, yet Hemispherx BioPharma, Inc. (AMEX: HEB) shares are up a solid 12% after the company announced a response to issues raised regarding Ampligen as a treatment for chronic fatigue syndrome. The FDA, in simplest terms, needed more information about the drug's...